Literature DB >> 26215211

Polypharmacy in Older Adults With Hypertension: A Comprehensive Review.

Bertrand N Mukete1, Keith C Ferdinand1.   

Abstract

Older adults are more likely to take more than two medications for medical conditions, and polypharmacy is associated with increased risk of adverse events (fall injury, hyperkalemia and hypokalemia, heart failure, and blood pressure exacerbation), polypharmacy mismanagement, drug-drug interaction, and increased costs. Knowledge of drugs that interact with known antihypertensive agents is paramount to avoiding or reducing adverse events, hospitalizations, and health care dollars. Innovative approaches such as use of a fixed-dose combination pill, ingestible sensor system, electronic reminder system, medical audits, and the integration of a pharmacist in the care of patients should be implemented to avoid polypharmacy mismanagement.
© 2015 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26215211      PMCID: PMC8031793          DOI: 10.1111/jch.12624

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  77 in total

1.  Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial.

Authors:  Robert S Bresalier; Robert S Sandler; Hui Quan; James A Bolognese; Bettina Oxenius; Kevin Horgan; Christopher Lines; Robert Riddell; Dion Morton; Angel Lanas; Marvin A Konstam; John A Baron
Journal:  N Engl J Med       Date:  2005-02-15       Impact factor: 91.245

2.  Evidence supporting a systolic blood pressure goal of less than 150 mm Hg in patients aged 60 years or older: the minority view.

Authors:  Jackson T Wright; Lawrence J Fine; Daniel T Lackland; Gbenga Ogedegbe; Cheryl R Dennison Himmelfarb
Journal:  Ann Intern Med       Date:  2014-04-01       Impact factor: 25.391

3.  Association between blood pressure and survival over 9 years in a general population aged 85 and older.

Authors:  Sari Rastas; Tuula Pirttilä; Petteri Viramo; Auli Verkkoniemi; Pirjo Halonen; Kati Juva; Leena Niinistö; Kimmo Mattila; Esko Länsimies; Raimo Sulkava
Journal:  J Am Geriatr Soc       Date:  2006-06       Impact factor: 5.562

4.  Effect of naproxen and acetaminophen on blood pressure lowering by ramipril, valsartan and aliskiren in hypertensive patients.

Authors:  Roberta Gualtierotti; Annalisa Zoppi; Amedeo Mugellini; Giuseppe Derosa; Angela D'Angelo; Roberto Fogari
Journal:  Expert Opin Pharmacother       Date:  2013-07-25       Impact factor: 3.889

5.  Peripheral vascular effects and pharmacokinetics of the antimigraine compound, zolmitriptan, in combination with oral ergotamine in healthy volunteers.

Authors:  R M Dixon; H B Meire; D H Evans; H Watt; N On; J Posner; P E Rolan
Journal:  Cephalalgia       Date:  1997-10       Impact factor: 6.292

6.  Acetaminophen increases blood pressure in patients with coronary artery disease.

Authors:  Isabella Sudano; Andreas J Flammer; Daniel Périat; Frank Enseleit; Matthias Hermann; Mathias Wolfrum; Astrid Hirt; Priska Kaiser; David Hurlimann; Michel Neidhart; Steffen Gay; Johannes Holzmeister; Juerg Nussberger; Pavani Mocharla; Ulf Landmesser; Sarah R Haile; Roberto Corti; Paul M Vanhoutte; Thomas F Lüscher; Georg Noll; Frank Ruschitzka
Journal:  Circulation       Date:  2010-10-18       Impact factor: 29.690

7.  Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS).

Authors: 
Journal:  Hypertens Res       Date:  2008-12       Impact factor: 3.872

8.  Prevalence and determinants of isolated systolic hypertension among young adults: the 1999-2004 US National Health And Nutrition Examination Survey.

Authors:  Regina C Grebla; Carlos J Rodriguez; Luisa N Borrell; Thomas G Pickering
Journal:  J Hypertens       Date:  2010-01       Impact factor: 4.844

Review 9.  Smoking and hypertension.

Authors:  P Sleight
Journal:  Clin Exp Hypertens       Date:  1993-11       Impact factor: 1.749

10.  Recombinant human erythropoietin (rHuEPO) increases endothelin-1 release by endothelial cells.

Authors:  R G Carlini; A S Dusso; C I Obialo; U M Alvarez; M Rothstein
Journal:  Kidney Int       Date:  1993-05       Impact factor: 10.612

View more
  14 in total

Review 1.  Dangers of Overly Aggressive Blood Pressure Control.

Authors:  Faisal Rahman; John W McEvoy
Journal:  Curr Cardiol Rep       Date:  2018-09-26       Impact factor: 2.931

Review 2.  A practical approach to the pharmacological management of hypertension in older people.

Authors:  Nikesh Parekh; Amy Page; Khalid Ali; Kevin Davies; Chakravarthi Rajkumar
Journal:  Ther Adv Drug Saf       Date:  2016-12-27

3.  Incremental effects of antihypertensive drugs: instrumental variable analysis.

Authors:  Adam A Markovitz; Jacob A Mack; Brahmajee K Nallamothu; John Z Ayanian; Andrew M Ryan
Journal:  BMJ       Date:  2017-12-22

4.  Evaluation of pharmacotherapy complexity in residents of long-term care facilities: a cross-sectional descriptive study.

Authors:  Vanessa Alves-Conceição; Daniel Tenório da Silva; Vanessa Lima de Santana; Edileide Guimarães Dos Santos; Lincoln Marques Cavalcante Santos; Divaldo Pereira de Lyra
Journal:  BMC Pharmacol Toxicol       Date:  2017-07-25       Impact factor: 2.483

5.  Target Organ Damage and the Long Term Effect of Nonadherence to Clinical Practice Guidelines in Patients with Hypertension: A Retrospective Cohort Study.

Authors:  Tadesse Melaku Abegaz; Yonas Getaye Tefera; Tamrat Befekadu Abebe
Journal:  Int J Hypertens       Date:  2017-06-13       Impact factor: 2.420

6.  Prevalence, awareness, treatment, and control of hypertension in older people: results from the population-based KORA-age 1 study.

Authors:  Samuel Muli; Christa Meisinger; Margit Heier; Barbara Thorand; Annette Peters; Ute Amann
Journal:  BMC Public Health       Date:  2020-07-02       Impact factor: 3.295

7.  Potential for physician communication to build favorable medication beliefs among older adults with hypertension: A cross-sectional survey.

Authors:  Song Hee Hong
Journal:  PLoS One       Date:  2019-01-07       Impact factor: 3.240

8.  Vasodilation Elicited by Isoxsuprine, Identified by High-Throughput Virtual Screening of Compound Libraries, Involves Activation of the NO/cGMP and H₂S/KATP Pathways and Blockade of α₁-Adrenoceptors and Calcium Channels.

Authors:  Daniella Medina-Ruiz; Berenice Erreguin-Luna; Francisco J Luna-Vázquez; Antonio Romo-Mancillas; Alejandra Rojas-Molina; César Ibarra-Alvarado
Journal:  Molecules       Date:  2019-03-11       Impact factor: 4.411

9.  Factors Associated With Medication Adherence In Elderly Retired Outpatients In São Paulo, Brazil.

Authors:  Juliana Martins Ribeiro Valassi; Nelson Carvas Junior; Mirian Matsura Shirassu; Kaleo Eduardo de Paula; Elena R Atkinson; Marcia Kiyomi Koike
Journal:  Patient Prefer Adherence       Date:  2019-09-30       Impact factor: 2.711

10.  Polypharmacy: a challenge for the primary health care of the Brazilian Unified Health System.

Authors:  Renata Cristina Rezende Macedo do Nascimento; Juliana Álvares; Augusto Afonso Guerra; Isabel Cristina Gomes; Micheline Rosa Silveira; Ediná Alves Costa; Silvana Nair Leite; Karen Sarmento Costa; Orlando Mario Soeiro; Ione Aquemi Guibu; Margô Gomes de Oliveira Karnikowski; Francisco de Assis Acurcio
Journal:  Rev Saude Publica       Date:  2017-11-13       Impact factor: 2.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.